ID: ALA2316965

Max Phase: Preclinical

Molecular Formula: C19H21N3O5S

Molecular Weight: 403.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H](N)C(=O)N(C)S(=O)(=O)c1cccc(-c2ccc3c(c2)CNC3=O)c1

Standard InChI:  InChI=1S/C19H21N3O5S/c1-11(23)17(20)19(25)22(2)28(26,27)15-5-3-4-12(9-15)13-6-7-16-14(8-13)10-21-18(16)24/h3-9,11,17,23H,10,20H2,1-2H3,(H,21,24)/t11-,17+/m1/s1

Standard InChI Key:  YRJXJNIQTBBLIO-DIFFPNOSSA-N

Associated Targets(Human)

Threonyl-tRNA synthetase 88 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Threonine--tRNA ligase 24 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 403.46Molecular Weight (Monoisotopic): 403.1202AlogP: 0.45#Rotatable Bonds: 5
Polar Surface Area: 129.80Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.15CX Basic pKa: 6.18CX LogP: 0.28CX LogD: 0.25
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -0.48

References

1. Teng M, Hilgers MT, Cunningham ML, Borchardt A, Locke JB, Abraham S, Haley G, Kwan BP, Hall C, Hough GW, Shaw KJ, Finn J..  (2013)  Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-based design.,  56  (4): [PMID:23362938] [10.1021/jm301756m]

Source